Subclinical vulvar papillomavirus infection

Area of Science:

• Gynecology
• Dermatology
• Infectious Diseases

Background:

• Subclinical human papillomavirus (HPV) infections of the vulva are often undetected.
• Early identification of vulvar HPV is crucial for managing potential cervical HPV and cervical intraepithelial neoplasia (CIN) risks.

Purpose of the Study:

• To determine the prevalence of subclinical vulvar HPV in a colposcopic series.
• To evaluate the predictive value of acetowhite lesions for HPV detection.
• To assess risk factors for subclinical vulvar HPV and the efficacy of beta-interferon treatment.

Main Methods:

• A consecutive series of 968 women undergoing colposcopy were evaluated for subclinical vulvar HPV.
• Acetowhite lesion patterns were analyzed for their predictive value in diagnosing HPV.
• Demographic data and presence of cervical HPV/CIN were correlated with vulvar HPV prevalence.
• A subset of 30 patients received beta-interferon treatment.

Main Results:

• Eighty-eight cases of subclinical vulvar HPV were detected, yielding an overall prevalence of 9%.
• Three specific acetowhite lesion patterns demonstrated a 72% predictive value for HPV.
• Prevalence was significantly higher in women under 25 (19.8%) and those with cervical HPV or CIN (40%).
• Beta-interferon treatment showed poor efficacy, with regression in only 2 out of 30 patients.

Conclusions:

• Routine vulvar inspection with acetic acid, alongside Papanicolaou tests, can aid in identifying high-risk patients.
• Younger age and presence of cervical HPV/CIN are significant risk factors for subclinical vulvar HPV.
• Beta-interferon is not an effective treatment for subclinical vulvar HPV.